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1. Introduction 
 
1.1. Historical Background 
 
The knowledge about the presence of the Eustachian tube reaches back to the 
ancient Egyptian times (1600 BC) [1]. First detailed anatomical characteristics of 
the Eustachian tube were obtained through anatomical dissections carried out by 
Bartolomeo Eustachio (1510-1574) [2,3], Antonio Maria Valsalva (1666 – 1723) 
[4,5] and Joseph Guichard Duverney (1648 – 1730) [6]. The role and functions of 
the Eustachian tube were first thoroughly described in physiology studies carried 
out by great otologists such as Adam Politzer (1835 – 1929) [7] and Joseph Toyn-
bee (1815 – 1866) [8] during the second part of the 19th century. In recent times, 
a comprehensive understanding of the tubal function and its contribution to mid-
dle ear pathology was gained thanks to excellent pathophysiology studies (Blue-
stone CD, Poe D and Ars B) [9-12]. Modern advances in functional tests and non-
invasive imaging modalities are promising to enlighten unknown aspects of tubal 
anatomy, physiology and pathophysiology in the following years. 
 
 
1.2. Anatomy 
 
The Eustachian tube, as part of serially connected organs including the palate, 
epipharynx, tympanic cavity, attic, aditus ad antrum, mastoid antrum and mastoid 
air cells, has a highly complex structure and localization [13] (Figure 1). Its anat-
omy is rather cleft-shaped than conduit-shaped [14], and it is located underneath 
the skull base [15]; it contains mucosa, cartilage and bone and is surrounded by 
soft tissue, such as the peri-tubal muscles (levator and tensor veli palatini, tensor 
tympani and salpingopharyngeus) and fat (Ostmann fat pad) [16]. It consists of 
two portions [15]: 
 
1. A cartilaginous part, starting from the pharyngeal orifice (torus tubarius) and 
running posterior, lateral and superior to the sulcus tubae, between the temporal 
bone (petrous portion) and the sphenoid bone (greater wing) [15], and 
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2. An osseous part, starting from the overlapping or junction area (narrowest point 
– isthmus) and directing to the protympanic space of the middle ear cavity [15]. 
 
After birth, its’ size constantly increases (approximately doubling) to reach 31-44 
mm in adulthood [15,17,24]. The length ratio between the cartilaginous and the 
osseous part is approximately two thirds to one third, respectively. “The angula-
tion of the longitudinal axis of the Eustachian tube to the horizontal plane of the 
skull is approximately 30-40 degrees in adults” [15,18]; in children the angle is 
much shallower angles (approximately 10 degrees) [18,19]. 
 
The lumen is covered by ciliated pseudostratified columnar epithelium (including 
mucosa-associated lymphoid tissue - MALT), which is essential for its function 
and is physiologically collapsed under normal ambient pressure conditions [14, 
20]. The opening of Eustachian tube occurs briefly through (inter-)action of the 
peri-tubal muscles and is triggered passively via swallowing or movement of the 
mandible during chewing, speaking or yawning [10, 21-23]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Localization and anatomy of the Eustachian tube. T: tympanic orifice, P: pharyngeal 
orifice, bp: bony portion, I: Isthmus, cp: cartilaginous portion (courtesy Spiggle & Theis Mediz-
intechnik GmbH, Overath, Germany). 
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1.3. Physiology  
 
The role of the Eustachian tube is thoroughly investigated and is crucial for the 
proper function of the middle ear, i.e. sound transmission from the tympanic mem-
brane to the inner ear [9]. Nevertheless, unknown aspects are still present, due 
to the complexity and inaccessibility of the anatomic structures and their various 
interactions with extrinsic and intrinsic parameters. The main functions of the Eu-
stachian tube are as follows [9]: 
 
1. Ventilation of the middle ear cavity and mastoid cell system via ascending gas 
transfer from the nasopharynx. 
2. Active and passive pressure equilibration of the middle ear cleft to the ambient 
atmospheric pressure. 
3. Descending mucociliary clearance of secretions from middle ear cavity and 
mastoid cell system. 
4. Mechanical protection against rhino-pharyngeal secretions from the nasophar-
ynx and ascendant sound (vocals) during the speech.  
6. Local immunological defence against ascendant infectious pathogens. 
 
 
1.4. Pathophysiology - Eustachian Tube Dysfunction 
 
According to the consensus statement of “experts in the field of Eustachian tube 
disorders, Eustachian tube dysfunction (ETD) is defined, in its broader sense, as 
an impairment of one of the functions mentioned above” [25]. In clinical practice, 
it comprises a failure of ventilatory and pressure equalization function. Therefore, 
it refers to a syndrome with a typical constellation of symptoms and signs result-
ing from pressure imbalance in the middle ear cavity: aural fullness and discom-
fort, subdued hearing, pressure in the ear, “popping” or “crackling”, impaired 
equalization manoeuvre and autophony. “The estimated prevalence in adults is 
approximately 1%; in children probably higher” [26]. 
Three types of Eustachian tube dysfunction are distinguished according to the 
specialists’ panel [25]: 
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1. “Dilatory Eustachian tube dysfunction: 
a. Functional obstruction 
b. Dynamic obstruction 
c. Anatomical obstruction 
2. Baro-challenge-induced Eustachian tube dysfunction 
3. Patulous Eustachian tube dysfunction” 
 
Currently, there are neither international consented diagnostic criteria nor a “gold 
standard” investigation to diagnose these pathologic conditions and thus screen-
ing affected patients and measuring outcomes after therapeutic interventions 
poses a challenge for the physician [27]. A combination of patient history and 
symptoms, clinical signs (otomicroscopy, nasopharyngoscopy), audiometric tests 
(tubomanometry, tympanometry) and statistically validated questionnaires (Eu-
stachian tube score - 7 and Eustachian tube dysfunction questionnaire - 7, s. 
chapter 2.3 Materials and Methods) are used in daily clinical practice for the di-
agnosis of this condition and to measure treatment effect [28]. 
 
 
1.5. Radiologic diagnostics 
 
High-resolution imaging studies provide an excellent method to evaluate the an-
atomical structure of the Eustachian tube. Furthermore, they are helpful in iden-
tifying accompanying pathologic conditions in the middle ear and nasopharynx, 
which could affect the proper function. Unfortunately, “no single modality provides 
details of all structures” [29] 
 
• Computed tomography (CT) imaging is a widely available and economical 
imaging modality, which provides fast acquisition of high-resolution images; 
it is superior for osseous Eustachian tube, internal carotid canal and air-
filled Eustachian tube lumen. It allows multiplanar reconstruction techniques 
and derivation of 3D images. 
• Magnetic resonance imaging (MRI) imaging, in comparison, is superior for 
cartilaginous Eustachian tube and surrounding soft tissue elements. MRI 
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can provide detailed characteristics of the mucosa, cartilage, Ostmann fat 
pad and associated peri-tubal muscles.  
 
Imaging investigations do not have an established role in assessing Eustachian 
tube dysfunction [25]. Therefore, Eustachian tube investigation remains a chal-
lenging task due to its’ elaborate and tortuous anatomical course underneath the 
skull base and the collapsed, cleft-shaped lumen under resting conditions. The 
dynamic nature of Eustachian tube function in terms of middle ear aeration, mu-
cociliary transport and fluid/sound protection makes this effort even harder. Sev-
eral techniques, non-invasive or invasive, with or without contrast agents have 
been applied in experimental and clinical settings till to date; none of them could 
dominate in clinical practice as a single modality, appropriate to evaluate overall 
function [29]. 
 
 
1.6. Research aims 
 
Since evidence regarding diagnostics of Eustachian tube function is currently 
sparse [27], the present study addresses the following objectives using clinical 
and radiological data elicited from current clinical practice with no extra cost, in-
tervention or burden to the patient: 
 
1. Determine whether morphological features of the Eustachian tube derived 
from CT-scans correlate with existent Eustachian tube scores, which reflect 
Eustachian tube function. Could radiological measurements be used as a 
valid diagnostic tool for Eustachian tube dysfunction? 
2. Investigate whether the radiological detection of mucus in Eustachian tube 
or adjacent middle ear cleft structures is associated with Eustachian tube 
dysfunction. Is mucus a valid indicator to detect the side of pathology? 
3. Determine whether secondary radiological findings regarding sinonasal pa-
thology (i.e. chronic rhinosinusitis) are associated with Eustachian tube 
scores. Is the presence of occult chronic rhinosinusitis associated with Eu-
stachian tube dysfunction? 
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4. Calculate the sensitivity, specificity, positive and negative predictive value 
of radiological evaluation on CT images to identify Eustachian tube dysfunc-
tion. Is the CT-scan an appropriate screening or diagnostic tool for Eusta-
chian tube dysfunction? 
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2. Materials and Methods 
 
2.1. Study Design 
 
This trial is a mono-centric, prospective, cross-sectional case series trial. The 
clinical, as well as the radiological data collection, was conducted consecutively 
between June 2016 and June 2017 in the Otolaryngology Department of ViDia 
Christian Hospitals Karlsruhe, Germany. The radiological dataset was then 
blindly processed at the Diagnostic and Interventional Neuroradiology Depart-
ment, University of Tuebingen, Germany. Finally, the statistical analysis was per-
formed at the Institute for Clinical Epidemiology and Applied Biometry of the Med-
ical Faculty of the University of Tuebingen, Germany. The local institutional re-
view board of the Medical Faculty of the University of Tuebingen, Germany, ap-
proved this study. The study did not receive any third-party funding. Overall data 
were anonymized and treated consonantly with the principles of the latest version 
of the Declaration of Helsinki. 
 
 
2.2. Patients 
 
Eligible patients were 16 years and older with the diagnosis of unilateral Eusta-
chian tube dysfunction (ETD). The diagnosis was established through medical 
history, ear microscopy (± Valsalva manoeuvre), tympanometry, tubomanometry 
and use of the Eustachian Tube scores (Eustachian tube score - 7 and Eusta-
chian tube dysfunction questionnaire - 7, s. chapter 2.3.1.). Furthermore, the rou-
tine pre-therapeutic assessment included computed tomography of temporal 
bone while performing a Valsalva-manoeuvre (chapter 2.3.3.). 
 
The study group comprised 80 Eustachian tubes of 40 patients (14 males aged 
mean 50,8 / SD 18,6 years and 26 females aged mean 49 / SD 16,7; age range 
17-87). Twenty out of forty patients had an accompanying middle ear pathology, 
for example, recurrent seromucous otitis or retraction process of the tympanic 
membrane. All patients denied any pre-existing sinonasal disease. 
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2.3. Diagnostics 
 
2.3.1. Eustachian tube dysfunction questionnaire - 7 (ETDQ-7) 
 
The “seven-item Eustachian tube dysfunction questionnaire or ETDQ-7” (Table 
1) is a statistically validated, easily administered, and robust patient-reported 
symptom score for identifying adult individuals suffering from Eustachian tube 
dysfunction [30]. It consists of seven disease-related questions, is side specific 
and has a quantitative response system ranging from “1 (no problem) to 7 (severe 
problem)” for each element. A total item score is consequently elicited, and the 
cutoff point is at 14,5, with an almost 100% sensitivity and specificity (discrimina-
tion between patients with ETD and healthy patients) [30,31]. Each patient filled 
the ETDQ-7 for each side as part of the routinely performed diagnostic assess-
ment. 
 
 
Table 1. The seven-item Eustachian tube dysfunction questionnaire (ETDQ-7) [30] 
Over the past month, how much has each of 
the following been a problem for you? 
No 
problem 
Moderate 
problem 
Severe 
problem 
1. Pressure in the ears? 1 2 3 5 4 6 7 
2. Pain in the ears? 1 2 3 4 5 6 7 
3. A feeling that your ears are clogged or 
“underwater”?  1 2 3 4 5 6 7 
4. Ear symptoms when you have a cold or 
sinusitis? 1 2 3 4 5 6 7 
5. Crackling or popping sounds in the ears? 1 2 3 4 5 6 7 
6. Ringing in the ears? 1 2 3 4 5 6 7 
7. A feeling that your hearing is muffled? 1 2 3 4 5 6 7 
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2.3.2. Eustachian tube score - 7 (ETS-7) 
 
The “Eustachian tube score seven or ETS-7” (Table 2) is likewise a novel, easily 
applied and reliable instrument for screening individuals with Eustachian tube 
dysfunction [32]. It combines subjective patient estimations regarding the ability 
of perforiming Valsalva and Toynbee manoeuvre, objective ear microscopy find-
ings during Valsalva manoeuvre, tympanometric and tubomanometric measure-
ments (at 30, 40 and 50 mbar). In this way, a total item score for each Eustachian 
tube is derived, ranging from “0 (pathologic condition) to 14 (healthy condition)”. 
This test discriminates the pathologic condition with a sensitivity and specificity 
of 96%, at a cutoff point of 7 [32]. For each patient, the ETS-7 score was calcu-
lated for each side as part of the routinely performed diagnostic assessment. 
 
 
Table 2. The Eustachian tube score 7 (ETS-7). TMM = tubomanometry. [32] 
Symptom / finding 2 points 1 point 0 points 
Clicking sound when swallowing always occasionally never 
Positive subjective Valsalva always occasionally never 
Objective Valsalva immediate weak and slow negative 
Tympanometry A C B 
TMM 30 mbar R ≤ 1 R > 1 no R 
TMM 40 mbar R ≤ 1 R > 1 no R 
TMM 50 mbar R ≤ 1 R > 1 no R 
 
 
2.3.3. Valsalva-CT-scan 
 
All scans were acquired using a third-generation single-source CT (SOMATOM® 
Definition AS+, Siemens Healthcare, Erlangen, Germany) with a fully integrated 
circuit detector (Stellar® detector, Siemens Healthcare, Erlangen, Germany). 
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The imaging parameters were as follows: gantry rotation time, 1.0 second; tube 
current, 230 reference mAs using an automatic tube current modulation (CARE 
Dose4D®, Siemens Healthcare, Erlangen, Germany) yielding an average tube 
current of 201 mAs and an average CT dose index (CTDIvol) of 41.3; tube voltage, 
120 kV; and pitch, 0.85. The detector collimation was 16 × 0.3 mm using a z-axis 
UHR and flying focal spot technique [33], resulting in 0.4-mm slice thickness. The 
scans were reconstructed using ADMIRE (Siemens Healthcare, Erlangen, Ger-
many) at a strength level of A2 [34]. 
 
During each CT scan of the temporal bone, the patient was instructed to simulta-
neously perform a Valsalva-maneuver to “enhance the visualization of the lumen 
of the Eustachian tube”, as previously described by Tarabichi et al. [35]. Detailed 
instructions were given by the technician to the patients how to perform a forceful 
exhalation against the closed nose (occlusion through digital compression). The 
patients were asked to maintain constant pressure during the whole duration of 
the scan. The CT-scan covered the skull base, including the entire anatomy of 
the Eustachian tube, the nasopharynx as well as the inner and middle ear struc-
tures. The image acquisition time was approximately 5 seconds. 
 
 
2.4. Image analysis 
 
2.4.1 Eustachian tube model  
 
The S-shaped schematic model of Kikuchi et al. [36] was used to approximate 
the Eustachian tube anatomy and perform morphological analyses (Figure 2a-c). 
Previous studies showed that its shape is curved with significant interindividual 
variance, and its volume is age-dependent [24, 37-38]. “Particularly in adults, the 
ET can be assumed as a gently curving, inverted S-shaped organ, although there 
is a range from almost straight to acutely curved [38]. Using CT with contrast 
injected into the ETs of cadavers, Oberascher et al. characterized the lumen 
shape like oval, except for the isthmus, which was found to be cylindrical [39]”. 
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Figure 2 a. Complete visualization of Eustachian tube (ET) lumen traced as a transradiant line 
on oblique planes of Valsalva-CT-scan [own archive] b. ET model after Kikuchi et al. [36] [own 
archive] and c. 3D volume rendering using software application ITK-SNAP, www.itksnap.org [84], 
[own archive]. P: pharyngeal orifice, T: tympanic orifice. 
 
 
 
b 
P 
T 
c 
P 
T 
a 
P 
T 
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2.4.2. Morphological measurements 
 
Image analyses were performed independently by two board-certified neuroradi-
ologists who were blinded to the clinical diagnoses. Before the study, both read-
ers underwent a simulation training with a separate anonymized dataset, includ-
ing ten temporal bone CT scans. Both readers had seven years of experience in 
temporal bone cross-sectional imaging. For inter-rater reproducibility, the intra-
class correlation coefficient (ICC) was measured. 
 
Image and region of interest (ROI) analyses were performed using Syngo.Via® 
(Siemens Healthcare, Erlangen, Germany). The Eustachian tube was delineated 
using a curved planar reconstruction (CPR). The following anatomical landmarks, 
according to Yoshida et al. [40,41] and Kikuchi et al. [36], were identified on the 
perpendicular images to the CPR centerline: 
 
1. “The pharyngeal orifice of the Eustachian tube: the area nearest the nasophar-
ynx where the Eustachian tube lumen appears semicircular.” 
2. “The tympanic orifice: the junction point in the delineated Eustachian tube be-
tween the posterior margin of the carotid canal and the basal turn of the cochlea” 
[modification due to different image reconstruction technique: in the present study 
curved planar reconstructions (CPR) versus axial multiplanar reconstruction 
(MPR) in Yoshida et al. [40,41] and Kikuchi et al. [36]] 
3. “The isthmus: the junction point between the bony and soft tissue portion of 
the Eustachian tube.” 
4. “The cartilaginous part of the Eustachian tube: the segment from the pharyn-
geal orifice to the isthmus.” 
5. “The bony part of the Eustachian tube: the segment from the isthmus to the 
tympanic orifice.” 
 
Using these landmarks on the reconstructed CT images, the following parame-
ters were measured: 
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S1: Cross-sectional size of the pharyngeal orifice of Eustachian tube  
The measurement of the cross-sectional size of the pharyngeal orifice on the 
coronal plane (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The cross-sectional size of pharyngeal orifice (S1) on a. ET 
model b. oblique plane and c. coronal plane [own archive]. 
 
 
S2: Cross-sectional size of the tympanic orifice of Eustachian tube 
The measurement of the cross-sectional size of the tympanic orifice on the coro-
nal plane (Figure 4). 
 
 
 
 
 
 
 
 
  
 
 
Figure 4. The cross-sectional size of tympanic orifice (S2) on a. ET model 
b. oblique plane and c. coronal plane [own archive]. 
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F: Full length of the Eustachian tube 
Tracing of the Eustachian tube lumen from the pharyngeal to the tympanic orifice, 
and measurement of its’ full length on the oblique plane (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Full length of Eustachian tube (F) on a. ET model and b. oblique plane [own 
archive]. 
 
 
C: Length of cartilaginous part, C1: Length of visualized cartilaginous part, C2: 
length of the non-visualized cartilaginous part 
The lumen of the cartilaginous Eustachian tube was traced as a hyper-lucent 
stripe starting from the pharyngeal orifice and directing to the isthmus. The full 
length of the cartilaginous portion was measured, as well as the visualized and 
non-visualized (collapsed) parts of it on oblique planes (Figure 6). 
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Figure 6. Full length of the cartilaginous portion of the Eustachian tube (C) on a. ET model 
and b. oblique planes., c. non-visualized cartilaginous part (C2) and d. visualized cartilagi-
nous part (C1) [own archive]. 
 
 
B: length of the bony part of Eustachian tube, B1: length of the visualized bony 
part, B2: length of the non-visualized bony part 
The lumen of the bony Eustachian tube was traced as a hyper-lucent stripe start-
ing from the isthmus and directing to the tympanic orifice. The full length of the 
bony portion was measured, as well as the visualized and non-visualized parts of 
it (Figure 7). 
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Figure 7. Full length of the bony portion of the Eustachian tube (B) on a. ET model and b. 
oblique planes. c. non-visualized bony part (B2) and d. visualized bony part (B1) [own ar-
chive]. 
 
 
I: Inclination angle to Frankfort horizontal plane 
Delineation of the inclination angle (Ia) on the sagittal MPR between Frankfort 
horizontal plane [42] and the tympanic orifice (T) (Figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Inclination angle (Ia) of the Eustachian tube (B) on a. ET model and b. coronal and c. 
oblique planes [own archive]. P: pharyngeal orifice, T: tympanic orifice. 
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Points P, T, L and M 
“The 3D coordinates for the centre of the pharyngeal (P) and the tympanic (T) 
orifice as well as for the most medial (M) and most lateral (L) points of the Eusta-
chian tube lumen were identified” [36] (Figure 9). These 3D coordinates were 
used to calculate the curvature angle (Ca) of the Eustachian tube and thus char-
acterizing its S-shape (larger C angle à deeper curvature, smaller C-angle à 
swallower curvature). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Curvature angle (Ca) of the Eustachian tube on a. ET model, b. P, L, T, M points on 
oblique planes, c., d., e., P, L, T, M points on coronal planes [own archive]. 
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After performing these measurements, seven morphological parameters were 
derived to conduct correlation studies with the Eustachian tube scores: 
 
1. S1: the cross-sectional size of the pharyngeal orifice of Eustachian tube 
2. S2: the cross-sectional size of the tympanic orifice of Eustachian tube 
3. V1: visualization percentage of overall Eustachian tube lumen on Valsalva-
CT-scan: derived from F, B, B1, B2, C, C1 and C2 
4. V2: visualization percentage of cartilaginous lumen on Valsalva-CT-scan: de-
rived from C, C1 and C2 
5. V3: visualization percentage of bony lumen visualization on Valsalva-CT-
scan: derived from B, B1 and B2 
6. Ia: inclination angle to Frankfort horizontal plane 
7. Ca: curvature angle of the S-shaped Eustachian Tube (derived from 3D co-
ordinates of the P, T, L and M points) 
 
 
2.4.3. Subjective image analysis – radiologists’ statement 
 
All CT images were reviewed for visual pathology of the bony middle ear struc-
tures as well as the adjacent nasopharynx and the nasal sinuses. Particular focus 
was laid on obstruction of the tympanic or pharyngeal orifice by mucus or fluid 
retention or other signs of chronic tympanic or mastoid ventilation disorder. Fi-
nally, a statement was derived: the radiologists (always blinded to the side of 
pathology) determined whether a Eustachian tube is pathologic or normal accord-
ing to their personal clinical experience in reviewing CT-scans of the temporal 
bone, without taking into account the morphologic measurements previously de-
scribed (2.3.2. Morphologic measurements). The average duration of image post-
processing, delineation of the ET, the definition of the anatomical landmarks, and 
qualitative image analysis was 15 minutes for one side. 
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2.5. Statistical analysis 
 
Statistical analysis was performed at the Institute for Clinical Epidemiology and 
Applied Biometry, Medical Faculty of University of Tübingen, Germany). The 
software used for this purpose was IBM SPSS Statistics (IBM Corp. Released 
2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.). 
Descriptive as well as inferential statistical methods were used; a p-value <0.05 
was considered to signalize statistical significance. In detail: 
 
For the 1st research aim, descriptive statistics (frequencies/percentages for cat-
egorical variables and mean/standard deviation/medians for continuous varia-
bles) were utilized to summarize the cohort’s characteristics. Intraclass correla-
tion coefficients (ICC) were calculated to prove the reproducibility of morpho-
logic measurement outcomes over different examiners. The Shapiro-Wilk test 
and the histogram parameters of skewness and kurtosis analyzed the Gaussian 
distribution in the clinical and the radiological variables. Following, non-paramet-
ric Wilcoxon rank test and parametric t-test compared the mean and median 
values between the pathological and healthy sides. The Pearson and Spear-
man correlation coefficients identified correlations between morphological fea-
tures and results of the clinical Eustachian tube scores. Finally, multivariate re-
gression models were constructed for significant cases from univariate analysis.  
 
For the 2nd research aim, the paired (dependent) sample t-test was used to test 
the presence of mucus in pathological and normal sides. Thereby the associa-
tion between mucus and Eustachian tube dysfunction was measured. 
 
For the 3rd research aim, the non-parametric McNemar test for nominal varia-
bles was used to investigate the association of accompanying nose pathology 
with the pathological side. Also, independent samples t-test has been per-
formed to check if the presence of an accompanying ear pathology or accompa-
nying sinonasal pathology or combinations of them (either, both) are affecting 
the Eustachian tube scores ETDQ – 7 and ETS-7. 
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For the 4th research aim, the sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) were calculated to investigate the 
validity of the subjective radiological assessment of patients with Eustachian 
tube dysfunction. 
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3. Results 
 
3.1. Cohort characteristics 
 
The baseline characteristics of the study group are summarized in Table 3. 
 
Table 3. Baseline characteristics of the study group 
 
Demographic characteristics All patients (n=40) 
Age mean 50 
Age range  17 - 87 
Age Standard Deviation 17,2 
Age median 51 
Gender 14 males / 26 females 
Percentage (%) 35% males / 65% females 
Pathologic conditions  
Side of pathology 22 left side / 18 right side 
Percentage (%) 55 % / 45% 
Accompanying ear pathology 20 with accompanying ear pathology 
/ 20 without 
Percentage (%) 50% / 50 %  
Eustachian tube scores   
ETDQ-7 mean standard deviation 
Normal side 10,7 4,8 
Pathologic side 25,4 9,9 
ETS7   
Normal side 10,2 2,8 
Pathologic side 5,2 3 
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3.2. Statistical analysis 
 
3.2.1. 1st research aim 
 
Are morphological measurements of Eustachian tube correlating with the 
Eustachian tube scoring system? Could radiological measurements be 
used as a valid diagnostic tool for Eustachian tube dysfunction? 
 
Summary of Eustachian tube scores and morphological measurements 
 
The variables, i.e. the Eustachian tube scores and the morphological measure-
ments, are summarized below: 
 
ETDQ-7: clinical Eustachian tube score 
ETS-7: clinical Eustachian tube score 
S1: the cross-sectional size of the pharyngeal orifice of Eustachian tube 
S2: the cross-sectional size of the tympanic orifice of Eustachian tube 
V1: visualization percentage of overall Eustachian tube lumen on Valsalva-CT-
scan 
V2: visualization percentage of cartilaginous lumen on Valsalva-CT-scan 
V3: visualization percentage of bony lumen on Valsalva-CT-scan  
Ia: inclination angle to Frankfort horizontal plane 
Ca: curvature angle of the S-shaped Eustachian Tube 
 
 
Test for inter-rater reliability 
 
The morphological characteristics of Eustachian tubes were measured inde-
pendently by two board-certified neuroradiologists, who were blinded to the clin-
ical diagnoses. For inter-rater agreement, the Intraclass Correlation Coefficient 
[ICC: two-way mixed-effects model, absolute agreement, average measures] and 
their 95% confident intervals were calculated (Table 4). 
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Table 4. Results of the Intraclass Correlation Coefficient. 
 
 ICC 95% Confidence Interval F Test p 
  Lower Bound Upper Bound value value 
Average measures .991 .989 .993 114,4 .000 
 
The average measure ICC was .991 with a 95% confidence interval from .989 
to .993 (F(212)=114,484, p=.000<.001).  
 
 
Tests for data distribution 
 
a. Normal sides measurements (Norm_ = values of healthy sides). 
 
Table 5 represents results of normality tests using Shapiro Wilk and Skew-
ness/Kurtosis for the variables Norm_ETDQ7, Norm_ETS7, Norm_S1, 
Norm_S2, Norm_V1, Norm_V2, Norm_V3, Norm_Ca and Norm_Ia. 
 
Shapiro Wilk: null hypothesis is that variables are normally distributed and the 
alternative that they are not. Variable Norm_S1 is normally distributed 
(W(40)=0,979, p=0,646>0,05) as well as variables Norm_V1 (W(40)=0,960, 
p=0,169>0,05), Norm_V3 (W(40)=0,958, p=0,140>0,05) and Norm_Ia 
(W(40)=0,972, p=0,413>0,05). Variable Norm_ETDQ7 is not normally distributed 
(W(40)=0,777, p=0,000<0,05) as well as Norm_ETS7 (W(40)=0,927, 
p=0,013<0,05), Norm_S2 (W(40)=0,895, p=0,001<0,05), Norm_V2 
(W(40)=0,916, p=0,006<0,05) and Norm_Ca (W(40)=0,933, p=0,021<0,05). 
 
Skewness/Kurtosis: values of skewness and kurtosis between -1 and 1 were 
found in normally distributed variables, confirming the results of the Shapiro Wilk 
test performed previously. A mismatch to Shapiro Wilk test was observed in var-
iable Norm_ETS7 (Skewness = -,605 and Kurtosis = -,469). After looking to the 
corresponding histogram, we assumed Norm_ETS7 as not normally distributed.  
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Table 5. Distribution of Norm_values. 
 
Variables Skewness Kurtosis W df p-value 
Norm_ETDQ7 1,693 3,677 ,777 40 ,000 
Norm_ETS7 -,605 -,469 ,927 40 ,013 
Norm_S1 ,472 ,242 ,979 40 ,646 
Norm_S2 1,376 2,742 ,895 40 ,001 
Norm_V1 -,234 -,967 ,960 40 ,169 
Norm_V2 -,378 -1,038 ,916 40 ,006 
Norm_V3 -,483 -,127 ,958 40 ,140 
Norm_Ca 1,032 2,880 ,933 40 ,021 
Norm_Ia ,071 -,461 ,972 40 ,413 
 
 
b. Pathological sides measurements (Path_ = values of pathological sides). 
 
Table 6 indicates results of normality tests using Shapiro Wilk and Skewness/Kur-
tosis for variables Path_ETDQ7, Path_ETS7, Path_S1, Path_ S2, Path_V1, 
Path_V2, Path_V3, Path_Ca and Path_Ia. 
 
Shapiro Wilk: null hypothesis is that variables are normally distributed and the 
alternative that they are not. Variable Path_ETDQ7 is normally distributed 
(W(40)=0,971, p=0,380>0,05) as well as variables Path_ ETS7 (W(40)=0,974, 
p=0,485>0,05), Path_S1 (W(40)=0,974, p=0,479>0,05), Path_S2 (W(40)=0,971, 
p=0,380>0,05) and Path_Ca (W(40)=0,985, p=0,856>0,05). Variable Path_V1 is 
not normally distributed (W(40)=0,917, p=0,006<0,05) as well as Path_V2 
(W(40)=0,899, p=0,002<0,05), Path_V3 (W(40)=0,774, p=0,000<0,05) and 
Path_Ia (W(40)=0,943, p=0,043<0,05). 
 
Skewness/Kurtosis: values of skewness and kurtosis between -1 and 1 were 
found in normally distributed variables, confirming the results of the previously 
performed Shapiro Wilk test. A marginal mismatch was found in two variables 
(Path_V1: Kurtosis = -,996, Path_Ia: Kurtosis = -,881). This mismatch may be 
due to their tendency to have values close to the cutoff-point of -1. However, after 
3. Results 
	 25	
looking at the corresponding histograms, they were considered as not normally 
distributed. 
 
Table 6. Distribution of Path_ values. 
 
Variables Skewness Kurtosis W df p-value 
Path_ETDQ7 ,300 -,735 ,971 40 ,380 
Path_ETS7 ,240 -,474 ,974 40 ,485 
Path_S1 ,462 -,067 ,974 40 ,479 
Path_S2 ,345 -,432 ,971 40 ,380 
Path_V1 -,544 -,996 ,917 40 ,006 
Path_V2 -,314 -1,370 ,899 40 ,002 
Path_V3 -1,551 1,478 ,774 40 ,000 
Path_Ca ,394 ,007 ,985 40 ,856 
Path_Ia ,282 -,811 ,943 40 ,043 
 
 
c. Difference between the normal and pathological side (Dif_ = value of normal 
side – value of pathological side). 
 
Table 7 indicates results of normality tests using Shapiro Wilk and Skewness/Kur-
tosis for the variables Dif_ETDQ7, Dif_ETS7, Dif_S1, Dif_S2, Dif_V1, Dif_V2, 
Dif_V3, Dif_Ca and Dif_Ia. 
 
Shapiro Wilk: null hypothesis is that variables are normally distributed and the 
alternative that they are not. Variable Dif_ETDQ7 is normally distributed 
(W(40)=0,97, p=0,357>0,05) as well as variables Dif_ETS7 (W(40)=0,962, 
p=0,197>0,05), Dif_S1 (W(40)=0,98, p=0,687>0,05), Dif_V1 (W(40)=0,964, 
p=0,234>0,05) and Dif_Ia (W(40)=0,977, p=0,590>0,05). Variable Dif_S2 is not 
normally distributed (W(40)=0,937, p=0,027<0,05) as well as Dif_V2 
(W(40)=0,797, p=0,000<0,05), Dif_V3 (W(40)=0,840, p=0,000<0,05) and Dif_Ca 
(W(40)=0,886, p=0,001<0,05). 
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Skewness/Kurtosis: values of skewness and kurtosis between -1 and 1 were 
found in normally distributed variables, confirming the results of the Shapiro Wilk 
test performed previously. 
 
Table 8 summarizes the distribution of test results. 
 
Table 7. Distribution of Dif_ values. 
 
Variables Skewness Kurtosis W df p-value 
Dif_ETDQ7 -,437 -,151 ,970 40 ,357 
Dif_ETS7 -,529 -,158 ,962 40 ,197 
Dif_S1 ,034 -,706 ,980 40 ,687 
Dif_S2 ,985 2,254 ,937 40 ,027 
Dif_V1 ,633 ,356 ,964 40 ,234 
Dif_V2 1,982 6,595 ,797 40 ,000 
Dif_V3 1,513 1,879 ,840 40 ,000 
Dif_Ca 1,411 5,631 ,886 40 ,001 
Dif_Ia ,189 -,500 ,977 40 ,590 
 
 
Table 8. Summary of data distribution results. 
 
Variable Distribution Variable Distribution Variable Distribution 
Norm_ETDQ7 not normal Path_ETDQ7 normal Dif_ETDQ7 normal 
Norm_ETS7 not normal Path_ETS7 normal Dif_ETS7 normal 
Norm_S1 normal Path_S1 normal Dif_S1 normal 
Norm_S2 not normal Path_S2 normal Dif_S2 not normal 
Norm_V1 normal Path_V1 not normal Dif_V1 normal 
Norm_V2 not normal Path_V2 not normal Dif_V2 not normal 
Norm_V3 normal Path_V3 not normal Dif_V3 not normal 
Norm_Ca not normal Path_Ca normal Dif_Ca not normal 
Norm_Ia normal Path_Ia not normal Dif_Ia normal 
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Mean and Median Comparison Analysis 
 
Non-parametric paired samples Wilcoxon Signed Rank Test compared medians 
of values between the pathological and healthy side, because of the non-normal 
distribution of data either in one or the other group (except variable S1, see Table 
8). Furthermore, the parametric paired sample T-test was performed due to its’ 
“robustness” to violations of normality, to cross-check the outcomes and compare 
the mean values in both groups. 
 
Null hypotheses are that the median of differences between the healthy and 
pathological sides equals zero and the mean values of morphological measure-
ments between healthy and pathological sides are equal respectively. Table 9 
summarizes coinciding results. A statistically significant difference of medians 
and means of variables V1 ( Z = -2,124, p = 0,034 < 0,05 and t(39) = 2,427, p = 
0,020 < 0,05 respectively) and V3 ( Z = -2,177, p = 0,029 < 0,05 and t(39) = 2,817, 
p = 0,008 < 0,05 respectively) between the healthy and pathological sides could 
be found. 
 
 
Table 9. Medians and Means comparison between normal and pathologic sides. 
 
Morphological 
measurements 
N Healthy 
side 
Pathological 
side 
Wilcoxon 
Signed Rank 
test 
Paired 
Sample 
T-Test 
  mean 
(SD) 
Mean 
(SD) 
Z 
(p-value)] 
t 
(p-value) 
S1 (m2) 40 34.7 
(16,1) 
31,2 
(14,1) 
-1,529 
(,126) 
1,670 
(,103) 
S2 (m2) 40 12,5 
(5,3) 
11,2 
(4,4) 
-1,378 
(,168) 
1,534 
(,133) 
V1 (%) 40 72,4 
(17,4) 
66,9 
(24,1) 
-2,124 
(,034) 
2,427 
(,020) 
V2 (%) 40 67,9 
(27) 
66,2 
(29,5) 
-,143 
(,886) 
,628 
(,533) 
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V3 (%) 40 80,7 
(12,1) 
67,91 
(28,9) 
-2,177 
(,029) 
2,817 
(,008) 
Ca (o) 40 10,4 
(3,3) 
9,6 
(3,3) 
-1,183 
(,237) 
1,254 
(,217) 
Ia (o) 40 30,1 
(3,9) 
29,8 
(3,6) 
-,316 
(,752) 
,461 
(,647) 
 
 
 
 
 
Correlation analysis 
 
Two separate correlation analyses were performed: primary for Dif_ values, i.e. 
difference between the normal and pathological side and secondary for Path_ 
values, i.e. absolute values of the pathological side. 
 
 
a. Correlation analysis for Dif_ variables 
 
• Dif_ETDQ7 
 
Non-parametric coefficient Spearman was used to correlate Dif_ETDQ7 with the 
non-normally distributed variables Dif_S2, Dif_V2, and Dif_V3, Dif_Ca, whereas 
parametric Pearson coefficient analyzed correlations between Gaussian distrib-
uted variables Dif_ETDQ7, Dif_S1, Dif_V1, and Dif_. Spearman’s and Pearson's 
coefficients take values in the interval [-1,1]. 
Values close to 1 indicate strong positive correlation while values close to -1 
strong negative. Values close to 0 indicate no correlation. The null hypothesis is 
that variables are correlated and the alternative that they are not. Table 10 indi-
cates that variable Dif_ETDQ7 does not correlate with any other variable. 
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Table 10. Correlation analysis for Dif_ETDQ7. 
 
Correlations Dif_ETDQ7 Coefficient 
Dif_S1 0,225 Pearson 
Dif_S2 0,065 Spearman 
Dif_V1 0,030 Pearson 
Dif_V2 0,173 Spearman 
Dif_V3 -0,028 Spearman 
Dif_Ca -0,013 Spearman 
Dif_Ia 0,138 Pearson 
 
 
 
• Dif_ETS7 
 
Non-parametric coefficient Spearman was used to identify correlations between 
Dif_ETS7 and the non-normally distributed variables Dif_S2, Dif_V2, Dif_V3, and 
Dif_Ca. Pearson coefficient correlated the values of normally distributed variables 
Dif_ETS7, Dif_S1, Dif_V1, and Dif_Ia. Table 11 and graphs 1 & 2 indicate that 
variable Dif_ETS7 is positive correlated with variables Dif_V1 (r=0,462, p<0,01, 
Pearson) and Dif_V3 (r=0,598, p<0,01, Spearman). 
 
 
Table 11. Correlation analysis for Dif_ETS7. 
 
Correlations Dif_ETS7 Coefficient 
Dif_S1 -0,194 Pearson 
Dif_S2 0,032 Spearman 
Dif_V1 ,436** Pearson 
Dif_V2 0,020 Spearman 
Dif_V3 ,598** Spearman 
Dif_Ca -0,152 Spearman 
Dif_Ia -0,094 Pearson 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Graph 1. Scatter diagram Dif_ETS7 * Dif_V1. 
 
 
 
Graph 2. Scatter diagram Dif_ETS7*Dif_V3. 
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b. Correlation analysis for Path_ variables 
 
• Path_ETDQ7 
 
Non-parametric coefficient Spearman was used to identify correlations between 
variable Path_ETDQ7 and variables Path_V1, Path_V2, Path_V3 and Path_Ia, 
which are not normally distributed. Parametric coefficient Pearson was used to 
identify correlations between variable Path_ETDQ7 and variables Path_S1, 
Path_S2 and Path_Ca, which are normally distributed. Table 12 indicates that 
variable Path_ETDQ7 is not correlated with any variable. 
 
Table 12. Correlation analysis for Path_ETDQ7. 
 
Correlations Path_ETDQ7 Coefficient 
Path_S1 -0,014 Pearson 
Path_S2 0,050 Pearson 
Path_V1 0,090 Spearman 
Path_V2 0,127 Spearman 
Path_V3 -0,052 Spearman 
Path_Ca 0,163 Pearson 
Path_Ia -0,066 Spearman 
 
 
• Path_ETS7 
 
Non-parametric coefficient Spearman was used to identify correlations between 
variable Path_ETS7 and variables Path_V1, Path_V2, Path_V3 and Path_Ia, 
which are not normally distributed. Parametric coefficient Pearson was used to 
identify correlations between variable Path_ETS7 and variables Path_S1, 
Path_S2 and Path_Ca, which are normally distributed. Table 13 and graphs 3 & 
4 indicate that variable Path_ETS7 is correlated with variables Path_S2 (r=0,361, 
p<0,05, Pearson) and Path_V1 (r=0,382, p<0,05, Spearman). 
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Table 13. Correlation analysis for Path_ETS7. 
 
Correlations Path_ETS7 Coefficient 
Path_S1 ,102 Pearson 
Path_S2 ,361* Pearson 
Path_V1 ,382* Spearman 
Path_V2 ,289 Spearman 
Path_V3 ,290 Spearman 
Path_Ca ,004 Pearson 
Path_Ia ,170 Spearman 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
 
 
Graph 3. Scatter diagram Path_ETS7 * Path_V1. 
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Graph 4. Scatter diagram Path_ETS7 * Path_S2. 
 
 
Regression analysis 
 
a. Regression analysis for Dif_ETS7 
 
Multivariate regression model further investigated significant cases from the uni-
variate correlation analysis. The aim was to establish a prediction model. Several 
linear regression variable selection methods (for example, forward selection, 
backward elimination) determined the best-fitting model. Table 14 indicates the 
results of the linear regression model fit using as dependent variable Dif_ETS7 
and independent variables Dif_V3 and Dif_Ca. Null hypothesis, that model does 
not fit data, is rejected (F(2,37)=13,14, p=0,000<0,05). Level of adjustment was 
good as Adjusted R2 = 0,384 ≅	0,4. 
 
 
Table 14. Results of the linear regression model fit for Dif_ETS7. 
 
R R2 Adj R2 F df1 df2 p-value 
,644* ,415 ,384 13,14 2 37 ,000 
* Predictors: (Constant), Dif_V3, Dif_Ca 
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Table 15 indicates that statistically significant indicators for dependent variable 
Dif_ETS7 are Constant (p=0,000<0,05) as well as variables Dif_V3 
(p=0,000<0,05) and Dif_Ca (p=0,013<0,05). Dif_ETS7 could be predicted using 
the following mathematical formula: 
 
Dif_ETS7= 4,08 + 0,09 x Dif_V3 – 0,39 x Dif_Ca 
 
 
Table 15. Coefficients of multiple linear regression model for Dif_ETS7. 
 
Independent variables B BETA p-value 
(Constant) 4,084  ,000 
Dif_V3 0,092 ,586 ,000 
Dif_Ca -,398 -,331 ,013 
Dependent variable: Dif_ETS7 
 
 
The influence (Graph 5) of variable Dif_V3 (BETA=0,586) is greater of Dif_Ca 
(BETA=-0,331). Lastly, the graph 6 represented the results of Dif_ETS7 and es-
timated Dif_ETS7 by the multiple linear models. 
 
 
 
Graph 5. Influence of independent variables to Dif_ETS7. 
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Graph 6. Prediction Model for Dif_ETS7. 
 
 
b. Regression analysis for Path_ETS7 
 
Table 16 indicates the results of the linear regression model fit using as depend-
ent variable Path_ETS7 and independent variables Path_V3 and Path_S2. Null 
hypothesis, that model does not fit data, is rejected (F(2,37)=7,195, 
p=0,002<0,05). Level of adjustment was moderate as Adjusted R2 = 0,241 < 0,4. 
 
Table 16. Results of the linear regression model fit for Path_ETS7. 
 
R R2 Adj R2 F df1 df2 p-value 
,529* ,280 ,241 7,195 2 37 ,002 
* Predictors: (Constant), Path_V3, Path_S2 
 
 
Table 17 indicates that statistically significant indicators for dependent variable 
Path_ETS7 are variables Path_V3 (p=0,008<0,05) and Path_S2 (p=0,048<0,05). 
Path_ETS7 can be predicted using the following mathematical formula: 
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Path_ETS7= 0,16 + 0,04 * Path_V3 + 0,2 * Path_ S2 
 
 
Table 17. Coefficients of multiple linear regression model for Path_ETS7. 
 
Independent variables B BETA p-value 
(Constant) ,167  ,907 
Path_V3 ,042 ,393 ,009 
Path_S2 ,200  ,292 ,046 
Dependent variable: Path_ETS7 
 
 
 
 
Influence (graph 7) of variable Path_V3 (BETA=0,393) is greater of Path_S2 
(BETA=0,292). Graph 8 represents differences between Path_ETS7 and esti-
mated Path_ETS7 by the multiple linear models. 
 
 
Graph 7. Influence of independent variables to Path_ETS7. 
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Graph 8. Prediction Model for Path_ETS7. 
 
 
3.2.2. 2nd research aim 
 
Is the radiological presence of mucus (M) in Eustachian tube or adjacent 
middle ear cleft structures associated with the pathological side? Is mucus 
a valid indicator to detect the side of pathology? 
 
Table 18 summarizes the results of mucus detection in normal and pathological 
sides. Mucus only occurred on pathological sides (n=10/40; 25%). 
 
Nevertheless, parametric paired sample t-test for dichotomic variables “patholog-
ical side” and “normal side” (no mucus versus mucus) was performed by common 
consent (no other statistical test could fit better in this case). The null hypothesis 
is that mean values are equal and the alternative that they are not. Table 18 
indicates that mean value of mucus presence in pathological side (M=25%) is 
statistically significant greater (t(39)=3,606, p=0,001<0,05) than mean value of 
mucus presence in normal side (M=0%). Graph 9 represents the results. 
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Table 18. Mucus presence in the pathological and healthy side. 
 
Side Mucus (M) Mean N df t p-value 
pathological 10 25% 40 39 3,606 0,001 
normal 0 0% 40    
 
 
 
 
Graph 9. Mucus presence in pathological and healthy sides. 
 
 
3.2.3. 3rd research aim 
 
Is the radiological detection of accompanying sinonasal pathology associ-
ated with the pathological side? Is the presence of accompanying sinona-
sal pathology or combination of accompanying nose and ear pathology af-
fecting ETDQ-7 and ETS-7 scores? 
A 2x2 contingency Table for the normal and the pathological side displays the 
outcomes 0 = no detection of accompanying sinonasal pathology and 1 = 
25 % (n=10)
0
0
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detection of accompanying sinonasal pathology (Table 19). The null hypothesis 
is that marginal probabilities for each condition are the same and the alternative 
that they are not. Performing McNemar test the null hypothesis is accepted 
(p=1,000 > 0,05); there is no significant difference in detection of accompanying 
sinonasal pathology between the pathological and healthy side. 
 
 
 
Table 19. Accompanying sinonasal pathology in pathological and healthy sides. 
 
 
 
 
Table 20 and graph 10 represent results of parametric independent sample t-test 
for Path_ETDQ7 and Path_ETS7 (scores of pathological sides) in cases of ac-
companying sinonasal pathology (presence or absence). The null hypothesis is 
that the mean values of the scores are equal, and the alternative that they are 
not. The mean value of Path_ETDQ7 in subjects which do not have accompany-
ing sinonasal pathology (mean = 25,84) does not differ significantly (t(38) = 0,453, 
p = 0,653 > 0,05) from mean value of subjects which have (mean = 24,11). Fur-
thermore, Path_ETS7 mean value of subjects which do not have accompanying 
sinonasal pathology (mean = 5,13) does not differ significantly (t(38)=-0,364, 
p=0,718>0,05) from mean value of subjects which have (mean = 5,56). 
 
 
 
 
  pathological side 
  0 (no sinonasal pathology) 1 (sinonasal pathology) 
normal side 0 (no sinonasal pathology) 28 4 
1 (sinonasal pathology) 3 5 
 
McNemar Test N=40 p-value= 1,000 
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Table 20. Eustachian tube scores in presence/absence of accompanying rhinologic pathology 
in pathological sides. 
Variables 
Accompanying 
sinonasal pathology 
N Mean df t p-value 
Path_ETDQ7 absence 31 25,84 38 0,453 0,653 
presence 9 24,11    
Path_ETS7 absence 31 5,13 38 -0,364 0,718 
presence 9 5,56    
 
 
 
Graph 10. Mean values of Path_ETDQ7 and Path_ETS7 in presence/absence of accompanying 
sinonasal pathology in pathological sides. 
 
 
Table 21 and graph 11 represent the results of parametric independent sample 
t-test for Path_ETDQ7 and Path_ETS7 (scores of pathological sides) in cases of 
accompanying sinonasal and otologic pathology (presence or absence of both 
conditions). The null hypothesis is that the mean values of the scores are equal, 
and the alternative that they are not. The mean value of Path_ETDQ7 in subjects 
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who do not have accompanying nose and ear pathology (mean = 25,57) does 
not differ significantly (t(38)=0,201, p= 0,842 > 0,05) from mean value of subjects 
who have both conditions (mean = 24,60). Moreover, Path_ETS7 mean value of 
subjects who do not have accompanying sinonasal and otologic pathology (mean 
= 5,26) doesn’t differ (t(38) = 0,174, p = 0,863 > 0,05) from mean value subjects 
who have both conditions (mean = 5,00). 
 
Table 21. Eustachian tube scores in presence/absence of accompanying sinonasal and otologic 
pathology on pathological sides. 
 
Variables 
Accompanying si-
nonasal and otologic 
pathology 
N Mean df t p-value 
Path_ETDQ7 
Absence 35 25,57 38 0,201 0,842 
Presence 5 24,60    
Path_ETS7 
Absence 35 5,26 38 0,174 0,863 
Presence 5 5,00    
 
 
Graph 11. Mean values of Path_ETDQ7 and Path_ETS7 in presence/absence of accompanying 
sinonasal and otologic pathology on pathological sides. 
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3.2.4. 4th research aim 
 
Is the radiological assessment of CT images a valid diagnostic tool for Eu-
stachian tube dysfunction? What are the sensitivity, specificity, positive 
and negative predictive values of radiological evaluation? 
 
Table 22 summarizes the results of radiologists’ statement concerning the status 
of the Eustachian tube.  
 
 
Table 22. Radiologists’ statements concerning Eustachian tube dysfunction.  
 
  Side of pathology (O) 
 
Radiologists’ 
statement 
(R) 
 
 Pathological (+) Normal (-) 
Pathological (+) 21 1 
Non-evaluable 18 18 
Normal (-) 1 21 
 
 
In 21 of 80 tubes, the radiologists could correctly detect the pathologic side; the 
contralateral side was correctly characterized as healthy (21 of 80). In 1 of 80 
tubes, they considered it pathological, but it was normal (false positive); the re-
verse happened for 1 of 80 tubes, that was considered normal but was pathologic 
(false negative). In 18 cases, i.e. in 36 of 80 tubes, the radiologists could not 
differentiate the side of pathology (non-evaluable cases). In these cases, the Eu-
stachian tubes presented regularly.  
 
Processing these results to determine the validity of radiologists’ statement could 
be done with different approaches: 
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1. “Intention to diagnose” principle [43] (Table 23) 
 
Table 23. “Intention to diagnose” principle. 
 
  Side of pathology (O) 
 
Radiologists’ 
statement 
(R) 
 
 Pathological (+) Normal (-) 
Pathological (+) 21 1+18=19 
Non evaluable 18 ¯ 18 ­ 
Normal (-) 1+19=19 21 
 
 
Sensitivity = !"
!"#"$
 = !"
%&
 = 52,5 % 
Specificity = !"
!"#"$
 = !"
%&
 = 52,5 % 
Positive predictive value = !"
!"#"$
 = !"
%&
 = 52,5 % 
Negative predictive value= !"
!"#"$
 = !"
%&
 = 52,5 % 
 
 
2. Non-evaluable results considered to be healthy (Table 24) 
 
Table 24. “Non-evaluable results considered to be normal” approach. 
 
  Side of pathology (O) 
 
Radiologists’ 
statement 
(R) 
 
 Pathological (+) Normal (-) 
Pathological (+) 21 1 
Non evaluable 18 ¯ 18 ¯ 
Normal (-) 1+19=19 21+18=39 
 
 
Sensitivity = !"
!"#"$
 = !"
%&
 = 52,5 % 
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Specificity = '$
'$#"
 = '$
%&
 = 97,5 % 
Positive predictive value = !"
!"#"
 = !"
!!
 = 95,4 % 
Negative predictive value= '$
"$#'$
 = '$
()
 = 67,2 % 
 
 
3. Excluding non-evaluable cases (Table 25) 
 
Table 25. “Excluding non-evaluable cases” approach. 
 
  Side of pathology (O) 
 
Radiologists’ 
statement 
(R) 
 
 Pathological (+) Normal (-) 
Pathological (+) 21 1 
Non-evaluable 18 18 
Normal (-) 1 21 
 
 
Sensitivity = !"
!"#"
 = !"
!!
 = 95,4 % 
Specificity = !"
!"#"
 = !"
!!
 = 95,4 % 
Positive predictive value = !"
!"#"
 = !"
!!
 = 95,4 % 
Negative predictive value= !"
"#!"
 = !"
!!
 = 95,4 % 
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4. Discussion 
 
4.1. General considerations 
 
The Eustachian tube represents a key factor for the proper function of the middle 
ear and subsequently hearing ability by its equalization, mucociliary drainage and 
protective functions. Impaired Eustachian tube function induces or contributes to 
the onset of frequent middle ear pathologies such as seromucous otitis, retraction 
process of tympanic membrane and cholesteatoma. Furthermore, its dysfunction 
probably leads to poor postoperative outcomes after performing middle ear sur-
gery and forces the physician to perform revision procedures. 
 
The development of novel therapeutical interventions for addressing Eustachian 
tube pathology in recent years, makes an accurate diagnostic tool even more 
essential. Minimal invasive techniques such as the “balloon dilatation of the Eu-
stachian tube (ETBD)” [44] have already proven their efficacy. They are widely 
established as the first-line treatment for patients suffering from impaired function 
of the Eustachian tube (dilatory and baro-challenged induced Eustachian tube 
dysfunction) [45,46]. Nevertheless, establishing the correct diagnosis remains a 
challenge for the physician due to the lack of a gold standard diagnostic proce-
dure [25]. 
 
Systematic reviews of Di Martino [47] and Smith et al. [28] showed that plenty of 
clinical tests for detecting Eustachian tube dysfunction have been applied in daily 
clinical practice in the past. However, up to now, none of them could provide an 
overall, detailed assessment of Eustachian tube physiology and pathophysiology. 
Patient questionnaires, such as the ETDQ-7 and ETS-7, represent a noninvasive 
and simple to use method to approach diagnostically pathological conditions and 
have gained much popularity in recent years [30-32, 48]. Especially the combi-
nation of both tests could lead to high diagnostic accuracy [28]. 
 
Besides, modern advances in imaging methods serve as an adjuvant workhorse 
for further understanding of Eustachian tube anatomy and function in the context 
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of Eustachian tube dysfunction [29]. The ideal radiological test should be simple, 
fast, non-invasive, low-cost and providing not only statical, anatomic information 
but also dynamic, functional aspects of tubal function. CT and MRI as radiological 
investigations could detect features associated with some form of Eustachian 
tube dysfunction [55-59, 71], “though more reliable assessment of function has 
only been achieved using contrast-enhanced radiography or scintigraphy” [29]. 
Till now, it is debatable whether the CT-scan should have a significant role in the 
preoperative diagnostic setting, or should apply for exceptional cases [49]. 
 
 
4.2. Cohort and imaging technique 
 
In the present study, the cohort consisted of adult patients diagnosed with unilat-
eral disease. This fact accommodated the advantage of having an internal control 
group and thus comparing radiologic findings between the pathological and 
healthy side. In this way, inter-individual differences in developmental and ana-
tomical features could be minimized. The subjects presented with characteristic 
symptoms for Eustachian tube dysfunction (aural pressure, impaired hearing, 
“crackling” ear sounds and insufficient equilibration Valsalva manoeuvre) and no-
body complained about sinonasal symptoms, such as nasal discharge, blocked 
nose, hyposmia or facial pain. Nevertheless, in 12/80 (15%) cases, ancillary si-
nonasal pathology could be identified (majorly chronic sinusitis of maxillary sinus 
with mucosa thickening, mucus or minor polyposis). Similar incidental sinus pa-
thology rates have been reported by Ani et al. (23%) [50] and Ashraf et al. (Lund-
MacKay CT score mean 4,26) [51] from the non-symptomatic population, show-
ing that this condition is frequent. 
 
The Valsalva-CT-technique was used to acquire the radiological dataset and as-
sess the morphology of the Eustachian tube. The Eustachian tube is usually col-
lapsed during the resting condition. Moreover, conventional CT scan does not 
offer the best possible contrast for evaluating the cartilaginous part (soft tissue). 
Therefore, the Valsalva-CT-technique was crucial to enhance the visualization of 
the lumen. According to Tarrabichi et al. [35], who proposed this technique in 
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2014, visualization of the entire length of cartilaginous part (approximately in 33% 
of cases) and significant increase of visualized length at the distal part of Eusta-
chian tube (in 71/76 patients, i.e. 94%) could be achieved. In our setting, this 
technique has been applied easily during the short image acquisition times (spiral 
CT), did not demand extra equipment and did not add additional expenses to our 
setting. Alper et al. [52] recently used an analogous approach to visualize the 
Eustachian tube lumen by obtaining CT-scan images during the forced response 
test (standardized pressure application in the nasopharynx), indicating an in-
creased interest to find a practical way to gain more radiological information about 
this complex organ.  
 
As mentioned before, the radiologic evaluation was performed independently by 
two neuroradiologists. For reliability, the Intraclass Correlation Coefficient [ICC: 
two-way mixed-effects model, absolute agreement, average measures] showed 
excellent inter-rater variability between the two physicians (ICC .991, 
F(212)=114,484, p=.000<.001) [53]. 
 
 
4.3. Morphological measurements  
 
The cross-sectional size of the pharyngeal and tympanic orifice of Eustachian 
tube 
 
There was a significant moderate positive correlation between Eustachian tube 
score ETS-7 and the cross-sectional size of tympanic orifice (S2) (r=0,361, 
p<0,05, Pearson) according to Cohen [54]. A bigger cross-sectional size of the 
tympanic orifice (S2) correlates with higher scores of ETS-7, indicating a better 
ventilation or pressure equalization function of the Eustachian tube. Similar re-
sults were found in previous studies; a reduced cross-sectional area of the tym-
panic segment correlated with the pathologic group compared to healthy individ-
uals (summary in Table 26). Measuring the tympanic orifice could be a specific 
imaging feature indicating obstructive Eustachian tube dysfunction and thus 
could be integrated into a preoperative evaluation protocol. 
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Table 26. Tympanic cross-sectional size as a predictive radiologic feature of Eustachian tube 
dysfunction, COM: Chronic Otitis Media, ETD: Eustachian tube dysfunction. 
 
Article Cohort characteristics Core findings 
Conticello et al. [55] 
1989  
• COM (n unknown), 
• controls (healthy subjects, n 
unknown) 
Constricted lumen found 
in COM 
Yoshida et al. [56] 
2007 
• 38 COM/obstructive ETD 
• 40 controls (healthy sub-
jects) 
Smaller bony framework 
found in COM/obstructive 
ETD 
Shim et al. [57] 
2010 
• 80 COM ad tympanoplasty 
• 100 controls (healthy sub-
jects) 
The small mean cross-
sectional area corre-
sponds to poor aeration 
subgroup 
Paltura et al. [58] 
2016 
• 232 COM/ETD (unilateral) 
• 232 internal controls (contra-
lateral ears) 
The bony diameter of ET 
less in COM/ETD side 
Nemade et al. [59] 
2018 
• 92 COM 
• 108 controls (healthy sub-
jects) 
ET pre-tympanic diameter 
significantly less in COM 
patients 
 
 
There was no correlation between Eustachian tube scores (ETDQ7 and ETS7) 
and the cross-sectional size of pharyngeal orifice (S1). Terzi et al. have reported 
the only coinciding literature data evidence in 2016 [60], who performed MRI-
morphologic measurements: the mean diameter of the pharyngeal orifice was not 
significantly different between the pathological and normal sides in 40 patients 
with suppurative otitis media (internal control group). 
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Visualization of the Eustachian tube lumen  
 
A significant difference was detected between normal and pathological sides in 
terms of visualization of Eustachian tube lumen. Particularly, the mean value of 
visualization grade of complete Eustachian tube (V1) and in its’ bony segment 
(V3) was higher in healthy sides rather than in pathological sides [Z = -2,124, p = 
0,034 < 0,05 / t(39) = 2,427, p = 0,020 < 0,05 and Z = -2,177, p = 0,029 < 0,05 
and t(39) = 2,817, p = 0,008 < 0,05 respectively]. Moreover, correlation between 
Eustachian tube score ETS-7 and visualization length of complete Eustachian 
tube (V1) and in its’ bony segment (V3) could be identified. The degree of corre-
lation between ETS7 and V1 (Dif_ analysis: r=0,436, p<0,01, Pearson / Path_ 
analysis: r=0,382, p<0,05, Spearman) could be considered as moderate to strong 
and the correlation between ETS7 and V3 (Dif_ analysis, r=0,598, p<0,01, Spear-
man) strong [54]. Greater visualization of the Eustachian tube on CT scans ac-
quired whilst performing a Valsalva maneuver is correlated with either higher 
scores of ETS-7 or a bigger difference of scores of the healthy and pathological 
side. Both conditions are reflecting a better function of the Eustachian tube. 
 
Evidence of analogous correlation could not be identified after comprehensive 
literature research in various clinical databanks (e.g. PubMed or Medline)  till to 
date. This could be due to difficulties of visualization of the Eustachian tube 
through conventional computer tomography. The simultaneously applied 
Valsalva manoeuvre provides the advantage of maximizing visualization, espe-
cially of the distal part (cartilaginous part) of the Eustachian tube, which is physi-
ologically collapsed and therefore not visible on CT-scan [35]. A study from 2007 
[61] has been performed on subjects with patulous Eustachian tubes and re-
vealed a significant difference of open tubal distance (equivalent to visualization 
grade in the current study) in the pathologic group versus the control group, con-
firming that “more visualized air space in the Eustachian tube correlates with a 
better ventilation function”. Various research groups reported implementations to 
delineate Eustachian tube lumen using MRI-imaging protocols for better soft-tis-
sue contrast [60, 62, 63]; limitations of these studies comprised either small case 
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numbers or inconsistent reporting of correlation between radiological findings and 
function tests of Eustachian tube.  
 
The strong correlation between the visualized bony segment and the scores sup-
ports our previous hypothesis (s. page 47) that measurements of the osseous 
part could offer us reliable predictive factors of proper Eustachian tube function. 
This statement comes in agreement with increasing endoscopic and histopatho-
logic evidence, concerning the essential pathophysiologic, obstructive role of the 
tympanic segment in the genesis of Eustachian tube dysfunction and subsequent 
middle ear pathologies [64-66]. 
 
 
 
Eustachian tube angles 
 
It is generally alleged that Eustachian tube’s shorter length and shallower angle 
to the skull base in childhood [18,19] is a major predisposing factor for reduced 
ventilation of middle ear cavity/mastoid, causing a higher prevalence of recurrent 
otitis media in this age group compared to adults [67,68].  
 
Results in the present study demonstrate that Eustachian tube scores ETDQ-7 
and ETS-7 are not correlated with the Eustachian tube inclination angle to the 
Francfort horizontal plane (Ia) [42]. A more horizontal position or swallower angle 
does not correlate with weak function in adults. This fact comes in agreement 
with conclusions of other authors, who described non-significant differences in 
inclination angle between healthy and diseased subjects (Table 27a). Only Tsai 
et al. [71], who compared ten ears (cholesteatoma) with the contralateral healthy 
side, found a significantly higher Eustachian tube angle in healthy ears (Table 
27b). 
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Table 27. The inclination angle of Eustachian tubes as a predictive radiologic feature of Eusta-
chian tube dysfunction, a: no correlation, b: correlation, OME: Otitis Media with effusion, COM: 
Chronic Otitis Media 
 
a. 
Article Cohort characteristics Core findings 
Takasaki et al. [18] 
2007 
• 54 OME in children 
• 50 controls, children without 
OME (healthy subjects) 
No significant difference of 
Eustachian tube angle be-
tween OME and healthy 
children group 
Dinc et al. [19] 
2015 
• 62 COM (Tympanosclerosis, 
retraction process, cholestea-
toma) 
• 62 internal controls (contrala-
teral ears) 
No significant difference in 
Eustachian tube angle be-
tween the pathological 
and normal side 
Yegin et al. [69] 
2016 
 
217 ears in 3 groups of differ-
ent grades of mastoid pneu-
matization (CT-morphologi-
cally) 
Eustachian tube angle is 
not significantly different 
throughout the three 
groups 
Yegin et al. [70] 
2017 
Group A Tympanoplasty 
• 39 good postop. outcomes  
• 39 internal controls (contrala-
teral ears) 
Group B Tympanoplasty 
• 12 poor postop. outcomes 
• 12 internal controls (contrala-
teral ears) 
No differences of Eusta-
chian tube angle between 
groups as well as patho-
logical-normal side 
b. 
Article Cohort characteristics Core findings 
Tsai et al. [71] 
2010  
10 attic cholesteatoma 
10 internal controls (contrala-
teral ear) 
Eustachian tube angle sig-
nificantly higher in healthy 
sides 
 
 
4.	Discussion	
	 52	
The shape, volume and consistency of Eustachian tube has been investigated 
thoroughly either by histopathological [22, 72] or radiological methods [38], and 
both showed excellent interindividual and age variance. For the first time in this 
study, we investigated the curvature angle of the Eustachian tube (Ca) and cor-
related it with the Eustachian tube scores. This angle indicates how curved or 
flattened a Eustachian tube is [36]. No significant correlation could be found be-
tween different degrees of curvature and Eustachian tube scores. 
 
 
Predictive models 
 
Multiple, linear regression was performed to assess the ability of morphologic 
measurements (independent variables) to predict Eustachian tube scores (de-
pended on variables). Following models have been constructed: 
 
1. Dif_ETS7= 4,08 + 0,09 x Dif_V3 – 0,39 x Dif_Ca 
 
2. Path_ETS7= 0,16 + 0,04 * Path_V3 + 0,2 * Path_ S2 
 
The Adjusted R2-values were 0,384 and 0,241 for the model (1) and (2) respec-
tively, indicating a low (to almost moderate) strength to predict the variance of 
Dif_ETS7 and Path_ETS7 using as predictors Dif_V3/Dif_Ca and Path_V3 
/Path_S2. Merely 38% of the variance of the response data can be explained by 
the model (1) and 24% for the model (2), demonstrating no significance for daily 
clinical practice. 
 
 
4.4. Co-factors of disease 
 
Although numerous studies evaluated the probability of a causal relationship be-
tween sinonasal pathology (i.e. acute or chronic rhinosinusitis) and Eustachian 
tube dysfunction in different ways (endoscopy findings, tympanometry, audiome-
try, tube ventilation tests), the clinical prevalence of this condition in patients is 
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yet uncertain [73]. The current established theory postulates that the inflamma-
tory disease of the nose negatively affects the function of Eustachian tube due to 
mucosal oedema (obstruction) and posterior sinonasal discharge (ascending in-
fection) [74]; the mucociliary clearance and pressure-equilibration is conse-
quently disturbed, giving rise to otologic symptoms (e.g. ear pressure, impaired 
hearing). The recognition of Eustachian tube dysfunction as a comorbidity of rhi-
nosinusitis is also reflected in the fact that widely used patient-reported rhinosi-
nusitis scores such as the “Sino-Nasal Outcome Test – 22” integrate otologic 
symptoms (“SNOT - 22 ear subdomain: ear fullness, dizziness, ear pain, facial 
pain/pressure”) [75]. A recent study showed a significant correlation between Eu-
stachian tube dysfunction score ETDQ-7 and SNOT-22, especially with its ear 
subdomain [76], implying a cause-effect relationship between the two conditions. 
However, this study could not find a correlation between ETDQ-7 and Lund-Mac-
kay CT score (staging score based on radiological findings of sinusitis) and Lund-
Kennedy endoscopy score (staging score based on endoscopic evidence of sinus 
disease). 
 
In the present study we assessed primarily, if the ancillary detection of rhinologic 
pathology (i.e. sinus pathology) in CT-scans concords with the pathologic side 
(tubal impairment). We found no association between radiological findings of si-
nus disease and side of Eustachian tube dysfunction (Mc Nemar, 
p=1,000>0,.05). Secondary, mean values of Eustachian tube scores ETDQ-7 and 
ETS-7 did not differ between sides with or without adjacent sinus pathology (in-
dependent sample t-test, t(38) = 0,453, p = 0,653 > 0,05 and t(38)=-0,364, 
p=0,718>0,05 respectively). Even in cases of accompanying sinonasal and ear 
pathology (radiological and clinical findings), the Eustachian tube scores mean 
values didn not differ (independent sample t-test, t(38)=0,201, p= 0,842 > 0,05 
and t(38) = 0,174, p = 0,863 > 0,05 respectively). This discrepancy between ob-
jective radiological findings and subjective symptoms appears consistent with the 
disclosures of Tangbumrungtham et al [76]: radiologic detection of rhinologic pa-
thology cannot be considered as a valid predictor to identify Eustachian tube dys-
function. 
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One of the main Eustachian tube functions is the descending mucociliary clear-
ance of secretions from middle ear cavity and mastoid cell system towards the 
nasopharynx [9]. Also, the mucosal lining of the Eustachian tube itself contains 
goblet cells which produce mucus capable of immunologic and transport proper-
ties [77]. Pathologic thickening of mucosa and excessive hyperplasia of goblet 
cells lead to increased production of mucus that may obstruct the Eustachian 
tube and compromise middle ear cleft ventilation [66, 77]. Especially in its nar-
rowest part, the isthmus, the impact of this condition could be enormous [65]. 
 
In contrary to sinonasal pathology, in our study, the radiologic detection of mucus 
in Eustachian tube or adjacent middle ear cleft structures was associated with 
the pathologic Eusatchian tube function. Mucus was detected in 10 ears/tubes 
out of 80; all of them corresponded to the pathologic side (n=10/40; 25%). The 
healthy tubes did not have signs of mucus retention or mucosal thickening. This 
could be an indication, that Eustachian tube dysfunction, at least in some pa-
tients, is caused by a pathological mucociliary clearance.  
 
 
4.5. The validity of radiologists’ statement 
 
Sensitivity, specificity, positive, and negative predictive values were calculated to 
evaluate the accuracy of radiologists in differentiating between pathologic and 
healthy Eustachian tubes using Valsalva-CT. The radiologists, who assessed the 
radiological dataset blinded to the side of diagnosis, could give a clear statement 
for 22 of 40 patients (55%). In 18 subjects (36 of 80 Eustachian tubes; 45%), the 
side of pathology could not be determined; this was due to symmetrical/equal 
presentation of Eustachian tubes on both sides and absence of any pathologic 
criteria (for example stenosis) and the subjective difference in visualization grade, 
posture or shape. Adjacent anatomic structures were without pathologic findings. 
Therefore, these Eustachian tubes were characterized primarily as non-evalua-
ble, but practically, presented as normal/healthy-appearing Eustachian tubes. 
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Different approaches were used to assess the data of the 3x2 Table, including 
the non-evaluable results (s. chapter “Results”, Table 22, page 42). The sensitiv-
ity of radiologists’ evaluation was 52,5 % regardless of method (“intention to di-
agnose principle” [43] and “non-evaluable considered normal approach”). The 
specificity, however, showed differentiation between the two methods: it was 
52,5% and 97,5% respectively. 
 
The approach “non-evaluable considered to be normal” is reflecting the standard 
condition in our study, since the radiologists labelled actually normal Eustachian 
tubes as non-evaluable results. The probability of correctly detecting the patho-
logic side is low (sensitivity 52,5%). That practically means, if the radiologist 
would see a regular Eustachian tube, he could rule out a pathologic tube with a 
probability of 52,5%. On the other hand, detecting correctly a normal Eustachian 
was much more probable (specificity 97,5%). Consequently, if the radiologist saw 
a pathologic Eustachian tube, he would establish the diagnosis of a diseased 
tube in 97,5%. Looking at the third approach, where non-evaluable cases were 
excluded, we can conclude that the radiologist had an excellent performance in 
detecting pathologic and healthy sides. In other words, if the radiologist could 
give a definite statement, then it would be probably correct. These results are 
following positive and negative predictive values. The following Table summa-
rizes the results (Table 28). 
 
 
Table 28. Diagnostic value of radiologic evaluation of Eustachian tubes, “non-evaluable consid-
ered normal” approach. 
 
Sensitivity = 52,5 % Positive predictive value = 95,4 % 
Specificity = 97,5 % Negative predictive value= 67,2 % 
 
 
4.6. Limitations 
 
Patients who have been included in the present study had an age ranging from 
17 to 87. Children were excluded from CT-scanning because of X-ray hazard and 
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no proven diagnostic benefit [49] even though this particular patient population 
seems to have the highest prevalence of Eustachian tube dysfunction [26]. An 
age-related data analysis could not be conducted because of the modest case 
number. Even though the development of the Eustachian tube is completed at 
the age of 7 [78], further age-related changes of Eustachian tube due to calcifi-
cation of soft tissue degeneration are not clarified yet [36,72]. Such developmen-
tal changes could have a great impact on Eustachian tube function. 
 
Twenty out of forty patients had an accompanying ear pathology such as  middle 
ear effusion or tympanic membrane retraction. Since the “interaction between 
middle ear disease and eustachian tube pathology is poorly understood” [79], this 
fact could influence our results. Furthermore, systemic comorbidities, such as 
gastroesophageal reflux have not been taken into account [80]. 
 
All Valsalva-CT-scans were acquired in the supine/recumbent position. This 
method has the handicap of venous/lymphatic blood congestion in peri-tubal soft 
tissue [41]. This condition consequently enhances the physiological collapse and 
reduces the patency of the already thin, cleft shaped Eustachian tube lumen. Ev-
idence in the literature indicates that air space in cartilaginous Eustachian tube 
lumen is larger in CT-scans acquired in the sitting position than in recumbent 
position; a significant difference does not exist at the bony part [41,61]. On the 
other hand, performing a CT-scan in sitting position demands a cone-beam CT 
system setting which is not widely available and established as the conventional 
one.  
 
Patients were thoroughly instructed on how to perform a Valsalva manoeuvre 
simultaneously to CT scan by experienced technicians who underwent a 3-month 
instruction period before data collection to optimize the investigation protocol. 
Nevertheless, we consider a bias source due to poor Valsalva technique, at 
equivalent rates as Tarabichi et al. [35] have reported previously (approx. 3%). A 
standardization of applied pressure in nasopharynx for opening would be favour-
able. 
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4.7 Future considerations 
 
Imaging evaluation of the Eustachian tube is gaining renewed interest since new 
therapeutic approaches to resolve its dysfunction have been introduced to clinical 
practice during the last years [29]. As shown in this study, conventional radiologic 
methods, which rely on static image acquisition (i.e. standard CT or MRI), cannot 
evaluate functional aspects of Eustachian tube and hence have faced critical re-
views [29, 49, 81]. Invasive or complex imaging methods like radiographic and 
scintigraphy tests could not be introduced into practicable clinical practice despite 
a possible potential [29]. The ultimate goal of establishing a golden standard ra-
diologic technique may be achieved by focusing on dynamic imaging techniques. 
Cine computed tomography protocols [82,83] and functional MR imaging [63] 
have presented promising results, although large scale trials have not been im-
plemented yet to prove their applicability. Advanced volume rendering protocols 
could be applied to generate 3D models [29], which could then be correlated to 
different pathologic conditions. This combination of dynamic imaging and 3D-re-
construction may perhaps help to clarify Eustachian tube dysfunction. 
 
 
4.8. Conclusion 
 
The current study examined whether morphological measurements of Eustachian 
tube in images obtained by Valsalva-CT scan are correlated with clinical Eusta-
chian tube scores and tried to clarify the value of radiologic assessment of the 
Eustachian tube and adjacent middle ear and nose structures in the diagnostic 
workup. The results show that the radiologic evaluation of Eustachian tube could 
provide us with detailed anatomic information about its complex structure but is 
insufficient to yield reliable data about its function. In addition, the sensitivity of 
radiologic assessment is rather low and hence is inappropriate as a screening 
tool for Eustachian tube dysfunction in daily clinical use. The x-ray exposure, the 
low predictive value and aspects of healthcare economics are not justifying using 
computed tomography of the temporal bone for routine diagnostic evaluation. The 
acquisition of CT-scan images should be reserved for individual enquiries such 
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as history of skull base trauma, congenital or developmental abnormalities, tu-
mour suspicion and revision surgery of Eustachian tube. If a patient presents with 
CT-scans of the temporal bone, then the focus of attention should be laid on the 
tympanic segment and the detection of mucus in the Eustachian tube or adjacent 
structures. 
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5. Abstract 
 
Objectives 
 
i. Investigate whether morphologic measurements of Eustachian tubes on 
computed tomography scans are correlated with Eustachian tube dysfunction 
scores. 
ii. Investigate whether sinonasal or middle ear radiological findings on temporal 
bone computed tomography are associated with the side of Eustachian tube 
dysfunction. 
iii. Determine the diagnostic validity of the computed tomography scan as a 
screening tool for Eustachian tube dysfunction. 
 
Study design 
 
Prospective, cross-sectional case series study in a tertiary referral centre (ViDia 
Christian Hospitals Karlsruhe). 
 
Methods 
 
The study included forty patients with clinically diagnosed unilateral Eustachian 
tube dysfunction, verified through Eustachian tube score – 7 and Eustachian tube 
dysfunction questionnaire – 7. 
 
Each patient underwent pre-interventional radiological assessment by temporal 
bone computed tomography while performing a Valsalva-maneuver to enhance 
visualization of Eustachian tube lumen. The complete course of Eustachian tube, 
from the epipharynx to the middle ear cleft was included in the scanning field. 
 
A curved planar reconstruction delineated the Eustachian tubes and 3D models 
were constructed using volume rendering software. Seven morphological param-
eters were independently measured for each Eustachian tube by two board-cer-
tified neuroradiologists blinded to the side of pathology: the cross-sectional size 
of the tympanic and pharyngeal orifice, visualization length of cartilaginous, bony 
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and overall Eustachian tube lumen as well as inclination angle to Frankfurt hori-
zontal plane and curvature angle of the S-shaped Eustachian Tube. Furthermore, 
the Eustachian tubes were analyzed for inter-side morphological differences, 
presence of mucus in the lumen or middle ear cleft and secretion retention or 
mucosal swelling in the adjacent sinuses. Finally, a radiological statement about 
the side of pathology was delivered, always blinded to the clinical diagnosis. 
 
Statistical correlation studies between morphological measurements and Eusta-
chian tube scores analyzed the association between the presence of mucus or 
accompanying sinonasal disease. Additionally, the diagnostic validity of the com-
puted tomography scan as a screening tool for Eustachian tube dysfunction was 
calculated. 
 
Results 
 
There was no significant correlation between Eustachian tube scores and the 
cross-sectional size of pharyngeal orifice. On the other side, correlation between 
Eustachian tube score - 7 and the cross-sectional size of tympanic orifice could 
be identified (r=0,361, p<0,05, Pearson). The mean value of visualization length 
of complete Eustachian tube and in its’ bony segment was higher in healthy sides 
rather than in pathological sides [Z = -2,124, p = 0,034 < 0,05 / t(39) = 2,427, p = 
0,020 < 0,05 and Z = -2,177, p = 0,029 < 0,05 and t(39) = 2,817, p = 0,008 < 0,05 
respectively]. Moreover, correlation between Eustachian tube score - 7 and visu-
alization length of complete Eustachian tube and in its’ bony segment could be 
identified (r=0,462, p<0,01, Pearson and r=0,598, p<0,01, Spearman respec-
tively). No significant correlation could be found between different grade of incli-
nation/curvature and Eustachian tube scores. 
 
The radiologic detection of mucus in Eustachian tube or adjacent middle ear cleft 
structures was associated with the pathological side. On the contrary, there is no 
association between radiological findings of sinus disease and side of Eustachian 
tube dysfunction. 
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The diagnostic value of radiologic assessment in Eustachian tube dysfunction 
has a sensitivity of 52,5 and specificity of 97,5%. 
 
Conclusion 
 
Measuring the tympanic orifice could be a specific imaging feature indicating ob-
structive Eustachian tube dysfunction and thus could be integrated into a pre-
operative radiological evaluation protocol. The sensitivity of radiologic assess-
ment is rather low. Hence, Valsalva-CT is inappropriate as a screening tool for 
Eustachian tube dysfunction in routine clinical practice. However, the presence 
of mucus in Eustachian tube or adjacent structures on temporal bone CT scan is 
the most specific morphologic correlate to Eustachian tube dysfunction.  
 
 
 
 
 
 
 
Savvas Kourtidis, 01.04.2020 
 
 
 
 
 
 
 
Prof. Dr. med. Serena Preyer, 01.04.2020 
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- German Translation of Abstract - 
 
Ziele der Studie 
 
i. Korrelation zwischen computertomographischen, morphologischen Messungen 
der Tuba Eustachii und den Tubenventilationsstörung-Scores. 
ii. Assoziation zwischen radiologischen Nebenbefunden der Nasennebenhöhlen 
oder des Mittelohrs und der Seite der Tubenventilationsstörung. 
iii. Diagnostische Validität der computertomographischen Untersuchung der 
Tuba Eustachii als “screening tool” für die Tubenventilationsstörung. 
 
Studiendesign 
 
Prospektive, Fall-Kontroll-Studie in einem Tertiärzentrum (ViDia Christliche Klini-
ken Karlsruhe) 
Methodik 
 
In die Studie wurden vierzig Patienten mit einer klinisch diagnostizierten, unilate-
ralen Tubenventilationsstörung eingeschlossen. Die Diagnosen wurden durch 
die Tubenventilationsstörung-Tests “Eustachian tube score – 7” und “Eustachian 
tube dysfunction questionnaire – 7” verifiziert.  
 
Jeder Patient bekam routinemäßig eine Computertomographie der Felsenbeine 
beiderseits. Die Durchführung eines Valsalva-Manövers während der Computer-
tomographie steigerte die Visualisierung der Tuba Eustachii. Der gesamte Ver-
lauf der Tuba Eustachii wurde abgebildet, vom Epipharynx bis hin zum Mittelohr. 
 
Durch “Curved Planar Reconstruction” konnten die Tuben dargestellt werden und 
durch “Volume Rendering” konnten 3D Modelle erstellt werden. Sieben morpho-
logische Parameter für jede Tube wurden von zwei erfahrenen Neuroradiologen, 
unabhängig und verblindet zu der klinischen Diagnose ausgewertet: die Quer-
schnittsfläche des pahryngealen und tympanalen Tubenostiums, die Länge der 
visualisierten Tube im gesamten, knorpeligen und knöchernen Anteil, der 
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Inklination Winkel zu der Frankfurter Horizontale und der Kurvatur Winkel der S-
förmigen Tuba Eustachii. Zusätzlich wurden Nebenpathologien in der Nase/Na-
sennebenhöhlen und im Mittelohr beurteilt. Anschließend mussten die Neurora-
diologen, die verblindet zu der klinischen Diagnose waren, entscheiden, welche 
Seite pathologisch aussah. 
 
Die statistische Auswertung der morphologischen Messungen und der Ergebnis-
sen der Tubenventilationsstörung-Scores erfolgte mit Korrelationskoeffizienten. 
Die Assoziation zwischen Nebenbefunden (Nase, Nasennebenhöhlen, Mittelohr) 
und pathologische Seite wurde erforscht. Die diagnostische Aussagekraft der 
computertomographischen Untersuchung der Tuba Eustachii als “screnning tool” 
für Tubenventilationsstörung wurde evaluiert. 
 
Ergebnisse 
 
Eine signifikante Korrelation zwischen “Eustachian tube score – 7” und Quer-
schnittfläche des tympanalen Tubenostiums konnte identifiziert werden (r=0,361, 
p<0,05, Pearson). Der Mittelwert der visualisierten Länge der Tuba Eustachii so-
wohl der gesamten Länge als auch im knöchernen Anteil war höher auf der ge-
sunden Seite als auf der pathologischen Seite [Z = -2,124, p = 0,034 < 0,05 / t(39) 
= 2,427, p = 0,020 < 0,05 und Z = -2,177, p = 0,029 < 0,05 und t(39) = 2,817, p 
= 0,008 < 0,05 entsprechend]. Eine Korrelation zwischen den Ergebnissen des 
“Eustachian tube score – 7” und der Länge der Visualisierung sowohl der gesam-
ten Länge als auch des knöchernen Anteils der Tuba Eustachii konnte identifiziert 
werden (r=0,462, p<0,01, Pearson and r=0,598, p<0,01, Spearman entspre-
chend). 
 
Der radiologische Befund von Mukus in der Tuba Eustachii oder im angrenzen-
den Mittelohr (Protympanon) war assoziiert mit der pathologischen Seite. Im Ge-
gensatz dazu, gab es keine Assoziation zwischen Nasenpathologie und Seite der 
Tubenventilationsstörung.  
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Die diagnostische Aussagekraft der computertomographischen Beurteilung der 
Tuba Eustachii bezüglich Tubenventilationsstörung beträgt eine Sensitivität von 
52,5%  und eine Spezifität von 97,5%. 
 
Schlussfolgerungen 
 
Lediglich die Detektion von Mukus in der Tuba Eustachii oder im angrenzenden 
Mittelohr (Protympanon) scheint ein radiologisches Merkmal zu sein, das gut mit 
der pathologischen Seite assoziiert ist. Die Sensitivität der computertomographi-
schen Untersuchung ist eher mäßig und ist deshalb als primäres diagnostisches 
Verfahren bei der Diagnostik der Tubenventilationsstörung nicht geeignet. Die 
Abklärung einer Tubenventilationsstörung allein stellt keine rechtfertigende Indi-
kation für die Durchführung einer Computertomographie des Felsenbeins dar. 
 
 
 
 
 
Savvas Kourtidis, 01.04.2020 
 
 
 
 
 
 
Prof. Dr. med. Serena Preyer, 01.04.2020 
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